PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Takalo, M.* ; Wittrahm, R.* ; Wefers, B. ; Parhizkar, S.* ; Jokivarsi, K.* ; Kuulasmaa, T.* ; Mäkinen, P.* ; Martiskainen, H.* ; Wurst, W. ; Xiang, X.* ; Marttinen, M.* ; Poutiainen, P.* ; Haapasalo, A.* ; Hiltunen, M.* ; Haass, C.*

The Alzheimer's disease-associated protective Plc gamma 2-P522R variant promotes immune functions.

Mol. Neurodegener. 15:52 (2020)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Background Microglia-specific genetic variants are enriched in several neurodegenerative diseases, including Alzheimer's disease (AD), implicating a central role for alterations of the innate immune system in the disease etiology. A rare coding variant in thePLCG2gene (rs72824905, p.P522R) expressed in myeloid lineage cells was recently identified and shown to reduce the risk for AD. Methods To assess the role of the protective variant in the context of immune cell functions, we generated a Plc gamma 2-P522R knock-in (KI) mouse model using CRISPR/Cas9 gene editing. Results Functional analyses of macrophages derived from homozygous KI mice and wild type (WT) littermates revealed that the P522R variant potentiates the primary function of Plc gamma 2 as a Pip2-metabolizing enzyme. This was associated with improved survival and increased acute inflammatory response of the KI macrophages. Enhanced phagocytosis was observed in mouse BV2 microglia-like cells overexpressing human PLC gamma 2-P522R, but not in PLC gamma 2-WT expressing cells. Immunohistochemical analyses did not reveal changes in the number or morphology of microglia in the cortex of Plc gamma 2-P522R KI mice. However, the brain mRNA signature together with microglia-related PET imaging suggested enhanced microglial functions in Plc gamma 2-P522R KI mice. Conclusion The AD-associated protective Plc gamma 2-P522R variant promotes protective functions associated with TREM2 signaling. Our findings provide further support for the idea that pharmacological modulation of microglia via TREM2-PLC gamma 2 pathway-dependent stimulation may be a novel therapeutic option for the treatment of AD.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
9.599
1.671
14
25
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Alzheimer's Disease ; Macrophage ; Microglia ; Knock-in Mouse Model ; Plcg2; Phospholipase-c; Microglia; Mutation; Plcg2; Activation; Pathway; Rac
Sprache englisch
Veröffentlichungsjahr 2020
HGF-Berichtsjahr 2020
e-ISSN 1750-1326
Zeitschrift Molecular Neurodegeneration
Quellenangaben Band: 15, Heft: 1, Seiten: , Artikelnummer: 52 Supplement: ,
Verlag BioMed Central
Verlagsort Campus, 4 Crinan St, London N1 9xw, England
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Developmental Genetics (IDG)
POF Topic(s) 30204 - Cell Programming and Repair
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-500500-001
G-500500-009
Förderungen Emil Aaltonen Foundation
Academy of Finland
Sigrid Juselius Foundation
Strategic Neuroscience Funding of the University of Eastern Finland
JPco-fuND2 2019 Personalised Medicine for Neurodegenerative Diseases
Horizon 2020 Framework Programme of the European Union (Marie Sklodowska Curie grant)
Orion Research Foundation
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology
DOI 10.1186/s13024-020-00402-7
WOS ID WOS:000570645300001
Scopus ID 85090894598
PubMed ID 32917267
Erfassungsdatum 2020-10-30
[➜Korrektur melden]